This is the supplier profile page of BioActa, where buyers can explore products, connect directly with the supplier for pricing inquiries.

Netherlands FlagNetherlands

3.4

Statensingel 2, 6217 KD Maastricht

40 inquiries

Add Favorite

|

Report Supplier

|

Business Description

  1. bioactiva diagnostica GmbH was founded in 2001 (originally in Frankfurt) and moved in 2004 to Bad Homburg. Bioactiva Diagnostica+2Medical Devices Directory+2
  2. It positions itself as a “one-stop provider” for in-vitro diagnostics, medical technology and laboratory equipment. Bioactiva Diagnostica+1
  3. Their product portfolio is broad: immunoassays, molecular diagnostics (e.g. PCR), microbiology, veterinary diagnostics, lab disposables, medical equipment and more. Bioactiva Diagnostica+1
  4. All their products are CE-certified, and the company’s quality management system is compliant with the standard EN ISO 13485. Bioactiva Diagnostica+1
  5. They claim to deliver worldwide — thanks to their central European location (near Frankfurt Airport) and a network of more than 80 distributors globally. Bioactiva Diagnostica+2Environmental Expert+2
  6. Their philosophy emphasizes client-orientation, flexibility, reliability, and providing tailored solutions. Environmental Expert+1

In short: bioactiva diagnostica is a German-based diagnostic & lab-equipment supplier/ manufacturer, offering a wide range of CE-certified lab products and kits to clinics, hospitals, and labs worldwide — aiming to be a comprehensive supplier (“one-stop”) for labs and healthcare providers.

Trade Capabilities

Business Terms

Preferred Payment Term:

Not specified

Preferred Trade Term:

Not specified

Port Of Loading:

Not specified

Accepted Currency:

USD

Trade Ability

Annual Revenue Amount:

Not specified

Numbers Of Employees:

11-50 employees

Certificates:

ISO, GMP

Avg Response Time:

≤ 1h

BioActa accepts USD, which simplifies payment for international buyers who already use US dollars. Without specified incoterms or port of shipment, buyers can't clearly understand who bears shipping costs or where goods are loaded — this creates uncertainty in logistics planning. Not knowing the transaction terms means buyers can't confirm if payment is due upfront, upon delivery, or under another condition, which increases risk. ISO and GMP certifications ensure BioActa meets strict quality and hygiene standards, which is critical for gaining trust in global food and pharmaceutical supply chains. With a team size of 11-50, BioActa is likely well-organized and capable of handling consistent, small-to-medium volume orders. The average inquiry response time of 2 hours shows they are responsive and can quickly address buyer needs, improving the chances of timely order processing.

Products / Services Offered

BioActa offers a wide range of services across agriculture, food and beverage, beauty, personal care, and sports — a mix that is uncommon for a single supplier. This broad portfolio suggests they may serve diverse markets, from food producers to wellness brands. Buyers looking for cross-category sourcing might find BioActa a unique option, though it could mean less specialization in any one area.

Supplier Verified

Verify work email

Verify phone number

Verify account email

BioActa has verified work email and phone number, which shows strong contact reliability, but missing document verification raises a red flag for buyer due diligence. While clear communication channels are in place, the lack of verified business documents means buyers can't confirm the company's legal standing or operational legitimacy. This combination suggests a trustworthy point of contact but requires extra caution before placing large orders.

Export Countries

Morocco FlagMorocco

South Africa FlagSouth Africa

North Africa

50%

Southern Africa

50%

BioActa eliminates geographic diversification beyond two regions, with a 50% presence in North Africa (Morocco) and 50% in Southern Africa (South Africa). This balanced but narrow footprint suggests a strategic focus on key African markets without regional expansion. The equal split indicates a deliberate, low-risk approach to emerging African economies.
Register Banner